Research & Development: Page 88
-
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar June 2007 June 17-21 DIA 43rd Annual Meeting Georgia World Congress Center, Atlanta PharmaVOICE is exhibiting at this event. For more information, contact Drug Information Association at 215-442-6100, e-mail [email protected], or visit diahome.org. June 18-19 3rd Annual Medical Devi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Strategic Patient Adherence Awards
The SPA Awards cosponsored by CBI and PharmaVOICE were presented at the 6th Annual Forum on Patient Compliance, Adherence and Persistency. 6th annual Forum on patient compliance, adherence and persistency Informative presentations, executive thought leadership, and a prestigious awards ceremony p...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies TGaS Advisors Offers Collaborative Benchmarking Services for Pharmaceutical Companies Pharmastance operational resource lets companies learn where they stand. TGaS Advisors has launched the Pharmastance family of benchmarks. These collabora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
These champions of industry demonstrate their commitment to their employees, their companies, and their communities by setting high personal and corporate standards. Mehmood Khan, M.D. Mehmood Khan, M.D.’s favorite quote is from Michelangelo: Ancora Imparo, which translates into “I am still learn...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Nanotech Comes of Age
By Kim Ribbink The once futuristic science of nanotechnology has come of age and branched into a broad spectrum of applications. Among these is nanomedicine: medicinal intervention at the molecular level for curing disease, repairing damaged tissue, and monitoring biological systems. The National...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Section 199 Deduction for Qualified Production Activity Income
In October of 2004, the U.S. Congress and President Bush signed into law the American Jobs Creation Act of 2004. The Act is the first major corporate tax act in over a decade. A key provision of the Act is a new domestic manufacturing deduction designed to improve the global competitiveness of U....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
One Step Ahead -- Dr. Mitchell S. Steiner
Bio An apt descriptor for Mitchell S. Steiner, M.D., F.A.C.S., is a man ahead of his time. This character trait has helped him in his academic background, in helping patients, and in establishing a biopharmaceutical company focused on novel hormonal therapeutics for cancer, muscle wasting, osteop...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar May 2007 Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies CIS Launches Pharma Compliance Exchange Website Compliance Implementation Services (CIS) recently released the Pharma Compliance Exchange (PCX), a new subscription-based source for government guidance documentation. For the first ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
May 2007 Table of Contents On the Cover Pharma’s Commitment to Public Health A natural extension of the industry’s mission of providing safe, lifesaving medicines is participation and sponsorship of myriad public-health initiatives around the world. Features Nanotech Comes of Age With products al...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
If you are feeling downtrodden by the continuing barrage of negative news about our industry, then this issue is the cure for what ails you. This issue showcases dozens of individuals who exemplify the best of the best in terms of their commitment, passion, and conviction to improving the health ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Consumer-Driven Healthcare Retail Primary Care One in 10 retail clinic users is replacing his or her primary-care physician with a retail clinic for the treatment of common ailments, according to a recent study by Market Strategies Inc. The study indicates substantial interest by consumers to rec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Connecting the Dots: The Big Picture in Connected Health While the adoption of electronic medical records (EMR) is enormously important — and a robust connected health vision depends on EMR — it is only one aspect of connected health as it exists today and as we envision it for tomorrow. — Joseph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Biotech: The States of the Industry — To harness talent and leverage the niche characteristics to grow business, the biosciences require the specific capabilities certain regions have to offer. In this special Forum, Governors from five biotech-centered states rep...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
An Agile Approach to Benefit Biotechnology Research
An Agile Approach to Benefit Biotechnology Research The biotechnology industry can take advantage of building upon the lessons learned by experienced contract research organizations that have performed clinical studies on behalf of pharmaceutical and medical-device sponsors. One of the best p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cardiac Safety and Efficacy: An Open Discussion
On Aug. 11, 2006, 16 representatives from ECG core labs located around the world convened in Milwaukee, Wisc., for a one-day meeting with Dr. Norman Stockbridge, Head of the Cardio-Renal Board of the Food and Drug Administration. Topics covered ranged from recent developments instituted by the FD...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
April 15-19 Society for Biomolecular Sciences 13th Annual Conference & Exhibition Palais de Congres de Montreal, Montreal, Canada For more information, contact Marietta Manoni, Society for Biomolecular Sciences, at 203-743-1336, e-mail [email protected], or visit sbsonline.org. April 16-17 ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Patient Eduction Programs to Grow in Use Patient education has a strong perceived value across multiple sectors of the healthcare industry. This value is expected to grow in 2007, according to results of a survey on patient education conducted by HealthEd. Among key findings of the first annual s...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
etrials Unveils New Version of EDC Solution etrials Worldwide has unveiled EDC 2.0 solution. Combining more than 10 years of market validation and customer deployments, the newest solution builds upon existing Web-based software as a service (SaaS) solution for collecting, managing, and analyzing...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Making Personalized Medicine Understandable Education is Key As William D. Young, CEO of Monogram Bioscience, states in The Age of Personalized Medicine, (PharmaVOICE February 2007), honestly and clearly addressing the concerns of the stakeholders (drug makers, insurance companies, doctors, and p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Whether we are discussing clinical studies or creative executions, there is a bit of artistry that is involved in executing the science. This concept is perfectly captured by two of this month’s feature articles. This month’s Forum, which discusses the evolving role of the clinical project manage...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DNA-Based Diagnostics: Testing for Personalized Medicine
By Cynthia Borda Theranostic testing There will come a time when genetic testing will be as common in the physician’s office as a blood pressure reading or the use of an MRI. The pharmaceutical industry is making headway in the personalized medicine arena, and diagnostic companies are actively de...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Nancy Smerkanich The U.S. Food and Drug Administration (FDA) called a Part 15 (21 CFR Part 15) hearing on Dec. 18, 2006, primarily as “a listening exercise” to gather information so that the agency could move forward to “an all electronic submission environment and electronic data ...
By Nancy Smerkanich • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents April 2007 On the Cover The Evolving Role of the Clinical Project Manager Clinical studies have become more complicated, are multinational, and must adhere to a variety of laws and regulations. As a result, the project manager role has become a core capability needed for drug de...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Connections
By Taren Grom, Editor Global outsourcing, as it relates to international sponsor/supplier relationships, is constantly changing and growing. Pharmaceutical companies and their partners can gain significant competitive advantages through global outsourcing when sound business practices are applied...
By Taren Grom • Jan. 2, 2008
Previous
